Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
81 participants
OBSERVATIONAL
2024-01-01
2024-11-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Higher Kinesiophobia
It is a group with a high level of kinesiophobia according to the "Tampa kinesiophobia scale".
No interventions assigned to this group
Lower Kinesiophobia
It is a group with a low level of kinesiophobia according to the "Tampa kinesiophobia scale".
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total knee arthroplasty surgery due to knee osteoarthritis
* Volunteering to participate in the study
Exclusion Criteria
* Diagnosed with rheumatoid arthritis
* Those with severe obesity (BMI \> 40 kg/m2)
* Those with sensory and motor impairments
* Revision knee arthroplasty planned
* Venous thromboembolism
* Neurological diseases (MS, Parkinson, etc.)
* Early post-surgical complications
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karabuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Musa Güneş
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Pursaklar Public Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Karabuk-006
Identifier Type: -
Identifier Source: org_study_id